| Literature DB >> 32168727 |
Laura Campo1, Mariem Hanchi2, Sabrina Sucato3, Dario Consonni1, Elisa Polledri3, Luca Olgiati1, Dalila Saidane-Mosbahi2, Silvia Fustinoni1,3.
Abstract
In this study, the urinary concentrations of selected metals in workers from an electric steel foundry in Tunisia were assessed and compared with existing biological limit values and general population reference values. Moreover, the association between oxidative DNA damage, measured as urinary 8-oxo-7,8-dihydro-2'deoxyguanosine (8-oxodG) and co-exposure to metals and polycyclic aromatic hydrocarbons (PAHs) was evaluated. Urinary levels of 12 metals were determined by inductively coupled plasma-mass spectrometry (ICP-MS) in end-shift spot samples from 89 workers. The urinary levels of phenanthrene (U-PHE), as marker of exposure to PAHs, and 8-oxodG were also available. Median levels ranged from 0.4 µg/L (cobalt, Co, and thallium, Tl) to 895 µg/L (zinc, Zn). Only 1% of samples was above the biological limit values for Co, and up to 13.5% of samples were above limit values for Cd. From 3.4% (Co) to 72% (lead, Pb) of samples were above the reference values for the general population. Multiple linear regression models, showed that manganese (Mn), Zn, arsenic (As), barium (Ba), Tl, and Pb were significant predictors of 8-oxodG (0.012 ≤ p ≤ 0.048); U-PHE was also a significant predictor (0.003 ≤ p ≤ 0.059). The variance explained by models was low (0.11 ≤ R2 ≤ 0.17, p < 0.005), showing that metals and PAHs were minor contributors to 8-oxodG. Overall, the comparison with biological limit values showed that the study subjects were occupationally exposed to metals, with levels exceeding biological limit values only for Cd.Entities:
Keywords: 8-oxo-7,8-dihydro-2′-deoxyguanosine; biological limit values; biological monitoring; electric steel foundry; metals; occupational exposure; polycyclic aromatic hydrocarbons; urine
Year: 2020 PMID: 32168727 PMCID: PMC7142962 DOI: 10.3390/ijerph17061811
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Urinary metal levels in all study subjects and in subjects stratified by job titles. Median (5th-95th) is shown for each metal. The results of the statistical comparison among job title is also reported.
| Metal | All Workers n = 89 |
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|
| RM-CF n = 33 | SSW n = 29 | MAN n = 12 | GALV n = 7 | QC n = 4 | ADM n = 4 | ||||
| Median (5th–95th) | |||||||||
|
| 0.85 (0.05–2.40) | 1.20 (0.6–2.87) | 0.67 (0.21–2.78) | 0.58 (0.03–1.97) | 0.10 (0.07–2.27) | 1.33 (0.05–1.49) | 0.61 (0.05–1.78) | 0.044 | |
|
| 0.75 (0.18–5.51) | 0.84 (0.16–5.51) | 0.57 (0.18–3.22) | 0.50 (0.07–1.82) | 1.00 (0.06–1.76) | 2.30 (0.18–7.01) | 0.84 (0.25–1.95) | 0.198 | |
|
| 0.6 (0.1–4.1) | 0.6 (0.1–2.8) | 0.5 (0.1–3.3) | 0.5 (0.2–5.0) | 1.1 (0.2–1.7) | 1.6 (0.1–4.1) | 2.4 (0.3–10.3) | 0.301 | |
|
| 0.4 (0.1–1.9) | 0.7 (0.2–4.2) | 0.2 (0.0–0.9) | 0.5 (0.1–1.2) | 0.6 (0.0–1.1) | 0.7 (0.2–2.2) | 0.7 (0.3–32.0) | 0.001 | SSW vs. MAN = 0.002 SSW vs. ADM = 0.010 |
|
| 2.4 (0.5–6.3) | 3.0 (0.7–6.1) | 2.1 (0.6–8.5) | 2.0 (0.5–5.4) | 1.5 (0.3–3.2) | 3.1 (0.8–6.2) | 3.3 (1.4–7.5) | 0.077 | |
|
| 25 (5–54) | 29 (10–50) | 11 (5–47) | 23 (4–62) | 25 (2–37) | 36 (7–51) | 41 (16–73) | 0.007 | SSW vs. RM-CF = 0.010 |
|
| 895 (137–3191) | 1054 (272–3185) | 390 (74–1270) | 1153 (260–3986) | 1533 (24–2750) | 765 (302–3618) | 3848 (862–7179) | <0.001 | SSW vs. MAN = 0.060 SSW vs. ADM = 0.002 SSW vs. RM-CF = 0.003 |
|
| 29 (3–156) | 26 (4–1053) | 30 (2–192) | 51 (9–155) | 48 (2–106) | 27 (9–139) | 41 (13–108) | 0.028 | SSW vs. MAN = 0.026 |
|
| 1.43 (0.10–4.57) | 1.83 (0.59–6.39) | 0.50 (<0.03–2.60) | 1.85 (0.34–2.80) | 1.88 (0.20–2.78) | 2.15 (0.55–5.08) | 3.23 (1.45–5.83) | <0.001 | SSW vs. MAN = 0.006 SSW vs. RM-CF < 0.001 SSW vs. MAN = 0.006 |
|
| 3.5 (0.3–17.0) | 5.4(1.6–17.0) | 1.6 (0.2–6.5) | 5.7 (1.0–16.7) | 3.5 (0.2–31.7) | 6.3 (2.1–10.3) | 4.1 (2.0–13.6) | <0.001 | SSW vs. MAN = 0.009 SSW vs. RM-CF < 0.001 |
|
| 0.4 (0.04–1.1) | 0.5 (0.1–1.5) | 0.1 (0.0–0.4) | 0.6 (0.2–0.9) | 0.5 (0.1–1.0) | 0.7 (0.1–1.0) | 0.6 (0.4–1.2) | <0.001 | SSW vs. MAN < 0.001 SSW vs. GALV = 0.022 SSW vs. RM-CF < 0.001 SSW vs. ADM = 0.004 SSW vs. QC = 0.053 |
|
| 5.0 (0.8–19.0) | 5.4 (2.0–19.1) | 2.1 (0.4–11.0) | 9.3 (3.0–19.0) | 7.4 (0.6–25.6) | 6.8 (2.9–12.5) | 8.2 (50–29.2) | <0.001 | SSW vs. MAN < 0.001 SSW vs. RM-CF < 0.001 SSW vs. ADM = 0.007 |
n = number of samples; a = p values represent significance of ANOVA for comparison among job titles; b = p values represent significance of ANOVA post hoc multiple comparison with Bonferroni correction (only p values ≤ 0.1 are shown).
Results of multiple linear regression analyses for predicting urinary levels of 8-oxodG as a function of metal exposure only (Model A) and as a function of co-exposure to metal and polycyclic aromatic hydrocarbons (PAHs), (Model B). Independent variables were the urinary levels of each single urinary metal in Model A, and the urinary levels of each single urinary metal plus urinary phenanthrene (U-PHE) in Model B.
| Model A | Model B | ||||
|---|---|---|---|---|---|
| Independent Variables | GMR (95% CI); | R2adjb; P c | Independent Variables | GMR (95% CI);
| R2adjb; P c |
|
| 0.82 (0.58–1.18); 0.282 | 0.04; 0.155 |
| 0.87 (0.62–1.23); 0.430 | 0.11; 0.017 |
|
| 2.42 (1.28–4.58); 0.007 | ||||
|
| 1.44 (0.93–2.21); 0.100 | 0.05; 0.087 |
| 1.40 (0.46–2.13); 0.110 | 0.13; 0.008 |
|
| 2.44 (1.30–4.57); 0.006 | ||||
|
| 1.88 (1.25–2.85); 0.003 | 0.12; 0.007 |
| 1.61 (1.04–2.50); 0.033 | 0.15; 0.004 |
|
| 1.90 (0.97–3.70); 0.059 | ||||
|
| 1.45 (0.95–2.21); 0.085 | 0.06; 0.079 |
| 1.37 (0.91–2.07); 0.128 | 0.13; 0.009 |
|
| 2.38 (1.27–4.47); 0.008 | ||||
|
| 1.36 (0.75–2.43); 0.306 | 0.03; 0.162 |
| 1.31 (0.74–2.30); 0.348 | 0.11; 0.016 |
|
| 2.46 (1.30–4.63); 0.006 | ||||
|
| 1.41 (0.80–2.49); 0.234 | 0.04; 0.141 |
| 1.32 (1.32–2.28); 0.323 | 0.11; 0.015 |
|
| 2.42 (1.28–4.57); 0.007 | ||||
|
| 1.79 (1.16–2.75); 0.009 | 0.10; 0.017 |
| 1.61 (1.05–2.48); 0.029 | 0.15; 0.003 |
|
| 2.17 (1.16–4.08); 0.016 | ||||
|
| 1.52 (1.08–2.13); 0.016 | 0.09; 0.025 |
| 1.47 (1.84–2.04); 0.021 | 0.16; 0.003 |
|
| 2.36 (1.28–4.38); 0.007 | ||||
|
| 1.38 (0.92–2.07); 0.114 | 0.06; 0.080 |
| 1.36 (1.84–2.04); 0.121 | 0.12; 0.010 |
|
| 2.35 (1.28–4.38); 0.009 | ||||
|
| 1.41 (0.96–2.07); 0.081 | 0.06; 0.077 |
| 1.45 (1.00–2.09); 0.048 | 0.14; 0.005 |
|
| 2.58 (1.38–4.80); 0.003 | ||||
|
| 1.82 (1.17–2.84); 0.008 | 0.10; 0.016 |
| 1.74 (1.13–2.67); 0.012 | 0.17; 0.002 |
|
| 2.33 (1.26–4.31); 0.008 | ||||
|
| 1.73 (1.07–2.81); 0.027 | 0.08; 0.037 |
| 1.62 (1.01–2.59); 0.046 | 0.14; 0.004 |
|
| 2.32 (1.24–4.34); 0.009 | ||||
GMR = geometric mean ratio. a = p values represent significance of each predictive variable. b = R2adj values represent the adjusted coefficient of determination for the linear regression model. c = P values represent the significance of the linear regression model.
Occupational limit values and reference values for the general population for urinary metals proposed by different organizations. The percentage of samples of study workers exceeding the biological values is shown.
| Metal | Biomarker | Organization | Sampling Time | Biological Value | Value | % of Samples Above the Biological Value | |
|---|---|---|---|---|---|---|---|
|
| DFG | End of exposure, for long-term exposures: at the end of the shift after several shifts | EKA | Air (mg/m3) | Biomarker (µg/g creatinine) | ||
| 0.025 | 35 | 0 | |||||
| 0.050 | 70 | 0 | |||||
| 0.100 | 140 | 0 | |||||
| SIVR | - | SIVR | 0.0250–0.855 µg/L | 48 | |||
|
| ACGIH | End of shift at end of workweek | BEI | 25 µg/L | 0 | ||
| Increase during shift | BEI | 10 µg/L | 2 | ||||
| DFG | End of shift | BAR | 0.6 µg/L | 63 | |||
| SIVR | - | SIVR | 0.050–0.60 µg/L | 63 | |||
|
|
| SIVR | - | SIVR | 0.040–1.5 µg/L | 15 | |
|
| ACGIH | End of shift at end of workweek | BEI | 15 µg/L | 1 | ||
| DFG | End of exposure, for long term exposure | EKA | Air (mg/m3) | Biomarker (µg/L) | |||
| 0.010 | 6 | 0 | |||||
| 0.025 | 15 | 0 | |||||
| 0.050 | 30 | 1 | |||||
| 0.100 | 60 | 0 | |||||
| 0.500 | 300 | 0 | |||||
| BLW | 35 | 0 | |||||
| BAR | 1.5 | 7 | |||||
| SIVR | - | SIVR | 0.077–2.2 | 3 | |||
|
| DFG | For long-term exposures: at the end of the shift after several shifts | EKA | Air (mg/m3) | Biomarker (µg/L) | ||
| 0.10 | 15 | 0 | |||||
| 0.30 | 30 | 0 | |||||
| 0.50 | 45 | 0 | |||||
| For long-term exposures: at the end of the shift after several shifts | BAR | 3 µg/L | 42 | ||||
| SIVR | - | SIVR | 0.372–4.44 µg/L | 19 | |||
|
| DFG | - | BAT | NA | |||
| - | BAR | NA | |||||
| SIVR | - | SIVR | 5.01–24.0 µg/L | 52 | |||
|
|
| SIVR | - | LVR | ND-1048 µg/L | 40 | |
|
| ACGIH | Not critical | BEI | 5 µg/g creatinine | 3 | ||
| ECHA | Not critical | BLV | 2 µg/g creatinine | 14 | |||
| DFG | Not fixed | BLW | NA | ||||
| Not fixed | BAR (NS) | 0.8 µg/L | 73 | ||||
| SIVR | - | SIVR | 0.100–0.900 µg/L | 69 | |||
|
| DFG | End of shift/ for long-term exposures: at the end of the shift after several shifts | BAR | 10 µg/L | 14 | ||
| SIVR | - | LVR | ND-6.97 µg/L | 24 | |||
|
|
| SIVR | - | SIVR | 0.0600–0.759 µg/L | 15 | |
|
|
| SIVR | - | SIVR | 1.170–2.94 µg/L | 72 | |
ACGIH = American Conference for Governmental industrial Hygiene; DFG = German Research Association (Deutsche Forschung Gemeinschaft); ECHA = European Chemicals Agency; SIVR = Italian Society for Reference Value. BAR = biological reference values for workplace substances; BAT = biological tolerance values (Biologische Arbeitsstoff-Toleranzwerte); BEI = Biological Exposure Index; BLV = biological limit values; BLW = biological guidance value (Biologische Leit-Werte); EKA = exposure equivalents for carcinogenic substances (Expositionsäquivalente für krebserzeugende Arbeitsstoffe); LVR = literature reference value; ND = not determined; NS = nonsmokers; NA = insufficient data for the derivation of a value.
Literature summary of biological monitoring studies reporting urinary metal levels in foundry workers. The production process and the analytical assay used to quantify metals in urine is also shown.
| Authors, Year | Production Process (Analytical Method) | N | V µg/L | Cr µg/L | Mn µg/L | Co µg/L | Ni µg/L | Cu µg/L | Zn µg/L | As µg/L | Cd µg/L | Ba µg/L | Tl µg/L | Pb µg/L |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| This Study, 2019 | Electric steel foundry (ICP-MS) | 89 | 0.85 (0.05–2.40) a | 0.75 (0.18–5.51) a | 0.6 (0.1–4.1) a | 0.4 (0.1–1.9) a | 2.4 (0.5–6.3) a | 25 (5–54) a | 895 (137–3191) a | 29 (3–156) a (total As) | 1.43 (0.10–4.57) a | 3.5 (0.3–17.0) a | 0.4 (0.04–1.1) a | 5.0 (0.8–19.0) a |
| Apostoli et al., 1988 | Cast iron foundry cupola furnace (X-ray fluorescence spectrometry) | 21 | - | 0.33 (0.06–1.04) b | ||||||||||
| Horng et al., 2003 | Steel production plant (Differential pulse Stripping voltammetry) | 63 | - | - | - | 8.18 (3.06–23.30) b | 33.10 (13.90–78.90) b | - | - | - | 9.52 (3.19–22.07) b | - | - | 53.50 (28.90–85.60) b |
| Afridi et al., 2009 | Steel mill Production (GFAAS) | 56 | - | - | 2.49 ± 0.7 c | 3.56 ± 0.6 c | - | 530 ± 5 c mg/L | - | 7.9 ± 1.8 c | - | - | - | - |
| De Palma et al., 2012 | Electric steel foundry (ICP-MS and AAS) | 339 | - | 0.44 (0.06–1.80) a | - | - | 0.90 (0.10–3.39) a | - | - | 6.40 (0.50–16.08) a, (inorganic As) | 0.28 (0.13–0.83) a | - | - | - |
| Soleo et al., 2012 | Integrated-cycle steel foundry (ICP-MS and AAS) | 49 | - | 0.10 < 0.10–0.40) d | 0.40 (0.00–1.80) d | 0.50 (0.08–1.20) d | 0.60 (0.20–3.00) d | 16.0 (3.3–51.0) d | 352 (67.0–2626.0) d | 5.0 (0.5–75.0) d, (inorganic As) | 0.40 (<0.006–1.40) d | 2.60 (0.20–12.00) d | - | 1.50 (0.20–9.20) d |
| Ściskalska et al., 2014 | Copper foundry (AAS) | 352 | - | S a: 12.76 e*NS a:13.0 e* (inorganic As) | S a: 0.83 e*NSa: 0.56 e* | |||||||||
| dos Santos et al., 2015 | Nonferrous metal foundries (GFAAS) | 178 | - | - | 0.64 (5.64) f | - | 1.8 (3.15) f | - | - | - | 1.27 (4.39)f | - | - | - |
| Wang et al., 2019 | Steel smelting plant (AAS) | 162 | - | - | - | - | 1.18 * (0.005–4.40) d | 6.44 * (0.0045–17.80) d | 0.93 * (0.17–3.15) d | 0.025 * (0.025–1.84) d |
N = number of samples; ICP-MS: Inductively coupled plasma-mass spectrometer; GF-AAS: Graphite furnace atomic absorption spectroscopy; S = smokers; NS = nonsmokers; a = median (5th–95th); b = mean (range); c = mean ± DS; d = median (range); e = mean; f = geometric mean (GSD); * µg/g creatinine.